← Back to Search

Dietary Supplement

Enovita Dietary Supplement for Cognitive Processes

N/A

Recruiting

Led By Jacob Wilson, Ph.D.

Research Sponsored by Applied Science & Performance Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on day 0, and day 28.

Awards & highlights

Study Summary

"This trial will study the effects of three different supplements on cognitive performance and mood over 4 weeks. They will enroll up to 76 healthy men and women between 25-55 years old, and

Who is the study for?

This trial is for healthy men and women aged 25-55 who can understand and follow the study's requirements. They must not have any cognitive impairments, cardiovascular, neurological, gastrointestinal, kidney or liver diseases, metabolic disorders like diabetes, cancer history or current treatment with chemotherapy/radiation. Pregnant or breastfeeding individuals and those on medications affecting digestion or with a history of substance abuse are excluded.Check my eligibility

What is being tested?

The study tests if Mirtoselect® (bilberry extract), Virtiva® Plus (ginkgo biloba extract), Enovita® (grape seed extract), or a placebo can improve cognitive performance and mood over four weeks. Participants will be randomly assigned to one of these four groups in blocks of four to ensure equal distribution.See study design

What are the potential side effects?

Potential side effects from the extracts being tested may include mild digestive upset as they interact with the body's processes. However, since this is a test for efficacy rather than toxicity, detailed side effects are not provided but will be monitored throughout the trial.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on day 0, and day 28.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on day 0, and day 28.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on day 0, and day 28. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Continuous Performance Test Results

Change in Finger Tapping Test (FTT) Results

Change in Shifting Attention Test Results

+4 more

Secondary outcome measures

Change in Abbreviated Profile of Mood States (POMS) Score

Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: Virtiva Dietary SupplementExperimental Treatment1 Intervention

One dose (1 capsule) will be consumed twice daily for 28 days. A single dose contains: 240mg Ginkgo biloba extract (leaf), 28.8mg 12% phosphatidylserine (from sunflower), and 12mg 5% ginkgo flavonglycosides.

Group II: Mirtoselect Dietary SupplementExperimental Treatment1 Intervention

One dose (1 capsule) will be consumed twice daily for 28 days. A single dose contains: 160mg bilberry extract (Vaccinium myrtillus L.) and 57.6mg 36% anthocyanosides.

Group III: Enovita Dietary SupplementExperimental Treatment1 Intervention

One dose (1 capsule) will be consumed twice daily for 28 days. A single dose contains: 150mg grape seed extract (Vitis vinifera L) and dried seed (cultivated), and 27.50mg 95% polyphenols.

Group IV: PlaceboPlacebo Group1 Intervention

One dose (1 capsule) will be consumed twice daily for 28 days. The placebo product will be rice flour (other ingredients: hypromellose, magnesium stearate and chlorophyll). Its appearance will be green/green oblong veggie capsule with white to off-white powder fill.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Applied Science & Performance InstituteLead Sponsor

11 Previous Clinical Trials

603 Total Patients Enrolled

Jacob Wilson, Ph.D.Principal InvestigatorThe Applied Science and Performance Institute

1 Previous Clinical Trials

15 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals who are older than 25 years eligible for enrollment in this medical study?

"Individuals seeking to participate in this research must be between 25 and 55 years old, adhering strictly to the age requirements set forth."

Answered by AI

What is the current number of individuals being recruited for participation in this research investigation?

"Affirmative. The details provided on clinicaltrials.gov highlight that this research initiative is actively seeking eligible individuals. Initial documentation for the trial was made public on February 21, 2024, with subsequent updates occurring until March 12, 2024. This investigation aims to enroll a total of 76 participants from a single designated site."

Answered by AI

Are there any vacancies available for patients to participate in this trial?

"Indeed, as per clinicaltrials.gov, this research investigation is actively seeking volunteers. The trial was first listed on February 21st, 2024 and its latest update was made on March 12th of the same year. There's a need for 76 participants at one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States

2024. "The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06309914.

All > Orlando > Tampa